Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP13 | P45452 | 10/20 | 1.00 |
| ▸ | MMP1 | P03956 | 6/20 | 1.00 |
| ▸ | MMP8 | P22894 | 1/20 | 0.61 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | MMP2 | P08253 | 1/20 | 0.49 |
| ▸ | MMP3 | P08254 | 1/20 | 0.49 |
| ▸ | MMP9 | P14780 | 1/20 | 0.49 |
| ▸ | MMP14 | P50281 | 1/20 | 0.49 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8206303 | 1.00 | MMP13 (1.00) | MMP13MMP1MMP8HTTNPSR1 | |
| SCHEMBL7212305 | 1.00 | MMP13 (1.00) | MMP13MMP1MMP8HTTNPSR1 | |
| SCHEMBL29296550 | 0.86 | MMP13 (0.76) | MMP13MMP1MMP8HTTNPSR1 | |
| SCHEMBL7212058 | 0.83 | MMP13 (0.71) | MMP13MMP1MMP8HTTNPSR1 | |
| SCHEMBL8204581 | 0.83 | MMP13 (0.71) | MMP13MMP1MMP8HTTNPSR1 | |
| SCHEMBL7212062 | 0.83 | MMP13 (0.71) | MMP13MMP1MMP8HTTNPSR1 | |
| SCHEMBL7409909 | 0.83 | MMP13 (0.71) | MMP13MMP1MMP8HTTNPSR1 | |
| SCHEMBL7212121 | 0.83 | MMP13 (0.71) | MMP13MMP1MMP8HTTNPSR1 | |
| SCHEMBL7212119 | 0.83 | MMP13 (0.71) | MMP13MMP1MMP8HTTNPSR1 | |
| SCHEMBL7212082 | 0.80 | MMP13 (1.00) | MMP13MMP1MMP8HTTNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6013649-A | BOND DISORDERS; AUTOIMMUNE DISEASES; ANTITUMOR AGENTS | MONSANTO COMPANY (US) | 2000-01-11 | — | — | US | disclosed |